<SEC-DOCUMENT>0001654954-20-004426-index.html : 20200424
<SEC-HEADER>0001654954-20-004426.hdr.sgml : 20200424
<ACCEPTANCE-DATETIME>20200424174929
ACCESSION NUMBER:		0001654954-20-004426
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20200424
DATE AS OF CHANGE:		20200424
EFFECTIVENESS DATE:		20200424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237845
		FILM NUMBER:		20816369

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>cvm_s8.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: cvm_s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.B
<SEQUENCE>2
<FILENAME>cvm_ex4b.htm
<DESCRIPTION>2020 NON QUALIFIED STOCK OPTION PLAN
<TEXT>
Document 2 - file: cvm_ex4b.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>3
<FILENAME>cvm_ex5.htm
<DESCRIPTION>OPINION ON LEGALITY
<TEXT>
Document 3 - file: cvm_ex5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>cvm_ex231.htm
<DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL
<TEXT>
Document 4 - file: cvm_ex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>cvm_ex232.htm
<DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL
<TEXT>
Document 5 - file: cvm_ex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>6
<FILENAME>cvm_ex99.htm
<DESCRIPTION>RE-OFFER PROSPECTUS
<TEXT>
Document 6 - file: cvm_ex99.htm

</DOCUMENT>
</SEC-DOCUMENT>